Humana shares are trading lower after the company said its EPS growth outlook will be impacted by several variables and said it no longer believes $6 to $10 of Adjusted EPS growth is the appropriate target range for 2025.
Portfolio Pulse from Benzinga Newsdesk
Humana's stock is trading lower following the company's announcement that its EPS growth outlook for 2025 will be affected by various factors, leading to the abandonment of its previous $6 to $10 Adjusted EPS growth target range.
April 24, 2024 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Humana's announcement of a revised EPS growth outlook for 2025, moving away from its $6 to $10 target range, has led to a decrease in its stock price.
Humana's revision of its EPS growth outlook directly impacts investor expectations and confidence, likely leading to a short-term decrease in stock price due to uncertainty and adjusted growth projections.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100